ID26254A - Komposisi farmasi yang terdiri dari satu gabungan antara metformin dan fibrate, dan penggunaannya dalam penyiapan obat-obatan yang ditujukan untuk menurukan hiperglikaemia - Google Patents

Komposisi farmasi yang terdiri dari satu gabungan antara metformin dan fibrate, dan penggunaannya dalam penyiapan obat-obatan yang ditujukan untuk menurukan hiperglikaemia

Info

Publication number
ID26254A
ID26254A IDW20001765A ID20001765A ID26254A ID 26254 A ID26254 A ID 26254A ID W20001765 A IDW20001765 A ID W20001765A ID 20001765 A ID20001765 A ID 20001765A ID 26254 A ID26254 A ID 26254A
Authority
ID
Indonesia
Prior art keywords
towarded
hyperglicemia
fibrate
metformin
join
Prior art date
Application number
IDW20001765A
Other languages
English (en)
Indonesian (id)
Inventor
Yves Bonhomme
Philippe Briet
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID26254A publication Critical patent/ID26254A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20001765A 1998-02-12 1999-01-30 Komposisi farmasi yang terdiri dari satu gabungan antara metformin dan fibrate, dan penggunaannya dalam penyiapan obat-obatan yang ditujukan untuk menurukan hiperglikaemia ID26254A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9801709A FR2774591B1 (fr) 1998-02-12 1998-02-12 Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie

Publications (1)

Publication Number Publication Date
ID26254A true ID26254A (id) 2000-12-07

Family

ID=9522912

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001765A ID26254A (id) 1998-02-12 1999-01-30 Komposisi farmasi yang terdiri dari satu gabungan antara metformin dan fibrate, dan penggunaannya dalam penyiapan obat-obatan yang ditujukan untuk menurukan hiperglikaemia

Country Status (27)

Country Link
US (1) US6372790B1 (de)
EP (1) EP1054665B1 (de)
JP (1) JP4767411B2 (de)
KR (1) KR100567608B1 (de)
CN (1) CN1151785C (de)
AR (1) AR018286A1 (de)
AT (1) ATE204754T1 (de)
AU (1) AU746821B2 (de)
BR (1) BRPI9907866B8 (de)
CA (1) CA2320039C (de)
CZ (1) CZ290101B6 (de)
DE (1) DE69900249T2 (de)
DK (1) DK1054665T3 (de)
ES (1) ES2162517T3 (de)
FR (1) FR2774591B1 (de)
HU (1) HU224619B1 (de)
ID (1) ID26254A (de)
MY (1) MY118164A (de)
NO (1) NO328314B1 (de)
PL (1) PL196874B1 (de)
PT (1) PT1054665E (de)
RU (1) RU2207850C2 (de)
SK (1) SK283212B6 (de)
TW (1) TW518222B (de)
UA (1) UA70315C2 (de)
WO (1) WO1999040904A2 (de)
ZA (1) ZA991077B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1039890B1 (de) * 1997-12-08 2004-03-17 Bristol-Myers Squibb Company Neue metformin salze und verfahren
US6982281B1 (en) 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
FR2796551B1 (fr) * 1999-07-23 2003-07-25 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
FR2796940B1 (fr) * 1999-07-26 2005-04-08 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
JP4879433B2 (ja) * 2000-01-13 2012-02-22 エミスフェアー・テクノロジーズ・インク 活性剤を送達するための化合物および組成物
US6531158B1 (en) * 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
JP4829411B2 (ja) * 2001-02-23 2011-12-07 キッセイ薬品工業株式会社 Ｃ型慢性肝炎治療剤
GB0119480D0 (en) 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
EP1424070A1 (de) * 2002-11-28 2004-06-02 Fournier Laboratories Ireland Limited Zusammensetzung von einem PPAR-alpha Agonisten und Metformin zur Senkung des Serumtriglyceridspiegels
JP2006511525A (ja) 2002-12-13 2006-04-06 ヤゴテック アーゲー ナノ粒子状スピロノラクトン局所製剤
RU2358738C2 (ru) * 2003-02-07 2009-06-20 Адзиномото Ко., Инк. Лекарственные средства для лечения сахарного диабета
FR2851734B1 (fr) * 2003-02-28 2006-06-09 Galenix Innovations Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
RU2241449C1 (ru) * 2003-09-25 2004-12-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция для лечения диабета (варианты)
US8062664B2 (en) * 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
RU2367423C2 (ru) 2003-12-19 2009-09-20 ОМЕГА БИО-ФАРМА (Ай.Пи. 3) ЛИМИТЕД Композиции и способы для лечения диабета
EP1559419A1 (de) * 2004-01-23 2005-08-03 Fournier Laboratories Ireland Limited Pharmazeutische Darreichungsformen enthaltend Metformin und ein Fibrat, sowie deren Herstellungsprozesse
US20070197602A1 (en) * 2004-02-09 2007-08-23 Hashime Kanazawa Combined pharmaceutical composition
EP1591114A1 (de) * 2004-03-12 2005-11-02 Fournier Laboratories Ireland Limited Verwendung von Metformin und Orlistat zur Behandlung oder Vorbeugung von Obesität
US20060286182A1 (en) * 2005-06-21 2006-12-21 Abeille Pharmaceuticals, Inc. Synergistic cinnamon combinations and methods for enhancing insulin activity
GB0602639D0 (en) * 2006-02-09 2006-03-22 Novartis Ag Organic compounds
WO2008015763A1 (fr) 2006-08-04 2008-02-07 Aska Pharmaceutical Co., Ltd. Formulation médicamenteuse contenant un médicament fibrate et procédé pour la produire
CN101342164B (zh) * 2007-08-21 2011-04-20 阜新市仙鹤制药有限责任公司 苯扎贝特控释制剂及其制备方法
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
ES2344183B1 (es) * 2009-02-18 2011-06-10 Italfarmaco, S.A. Uso de agentes sensibilizantes a insulina por via vaginal.
US9339458B2 (en) * 2009-02-18 2016-05-17 Itf Research Pharma, S.L.U. Use of vaginal insulin sensitizing agents
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
JP2012171911A (ja) 2011-02-22 2012-09-10 Kao Corp Ｐｐａｒ活性化剤
EP2872483A4 (de) * 2012-07-10 2016-03-16 Thetis Pharmaceuticals Llc Trisalzform von metformin
US8765811B2 (en) * 2012-07-10 2014-07-01 Thetis Pharmaceuticals Llc Tri-salt form of metformin
US9382187B2 (en) * 2012-07-10 2016-07-05 Thetis Pharmaceuticals Llc Tri-salt form of metformin
WO2015171516A1 (en) 2014-05-05 2015-11-12 Thetis Pharmaceuticals Llc Compositions and methods relating to ionic salts of peptides
WO2015183794A1 (en) 2014-05-27 2015-12-03 City Of Hope Tgr5 agonist complexes for treating diabetes and cancer
CN107074884A (zh) 2014-06-18 2017-08-18 西蒂斯制药有限责任公司 活性剂的矿物质氨基酸复合物
US9242008B2 (en) 2014-06-18 2016-01-26 Thetis Pharmaceuticals Llc Mineral amino-acid complexes of fatty acids
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
FR3050112B1 (fr) * 2016-04-15 2020-09-04 Soc Civ Immobiliere Gecinq Utilisation de l'acide fenofibrique dans le traitement des maladies hepatiques
JP6906047B2 (ja) 2016-06-03 2021-07-21 テティス・ファーマシューティカルズ・エルエルシー 特異的炎症収束性メディエーターの塩に関連する組成物及び方法
US10344002B2 (en) 2016-09-26 2019-07-09 Nusirt Sciences, Inc. Compositions and methods for treating metabolic disorders
FR3056908B1 (fr) * 2016-09-30 2019-04-19 Nashpharm Sel de metformine et d'elafibranor presentant une activite duale pour le traitement de l'obesite associee a la steato-hepatite non alcoolique (nash) et a l'hypertriglyceridemie
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
EP3824296A4 (de) 2018-07-20 2022-04-27 Lipocine Inc. Lebererkrankung
GB2599950A (en) * 2020-10-16 2022-04-20 Zentiva Ks Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
US20250127900A1 (en) * 2021-12-22 2025-04-24 Mankind Pharma Ltd. Stable pharmaceutical compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2264525B1 (de) * 1974-03-22 1977-11-04 Expl Marques Brevets Et
US4080472A (en) 1974-03-22 1978-03-21 Societe D'etudes Et D'exploitation De Marques Et Brevets S.E.M.S. Metformin 2-(p-chlorophenoxy)-2-methylpropionate
DE3729209A1 (de) * 1987-09-01 1989-03-09 Boehringer Mannheim Gmbh Verwendung von bezafibrat zur behandlung von diabetes
NZ240214A (en) * 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
JP3852621B2 (ja) * 1992-01-21 2006-12-06 あすか製薬株式会社 血管内皮細胞機能改善剤
WO1998005331A2 (en) * 1996-08-02 1998-02-12 Ligand Pharmaceuticals Incorporated Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators

Also Published As

Publication number Publication date
DE69900249D1 (de) 2001-10-04
CA2320039C (en) 2008-07-22
ES2162517T3 (es) 2001-12-16
KR20010040925A (ko) 2001-05-15
BR9907866A (pt) 2000-10-31
ZA991077B (en) 1999-08-11
BRPI9907866B8 (pt) 2021-05-25
NO328314B1 (no) 2010-01-25
NO20004056D0 (no) 2000-08-11
CZ290101B6 (cs) 2002-05-15
MY118164A (en) 2004-09-30
EP1054665A2 (de) 2000-11-29
PL196874B1 (pl) 2008-02-29
ATE204754T1 (de) 2001-09-15
CN1290160A (zh) 2001-04-04
FR2774591A1 (fr) 1999-08-13
JP4767411B2 (ja) 2011-09-07
BRPI9907866B1 (pt) 2017-08-15
CA2320039A1 (en) 1999-08-19
HUP0100801A2 (hu) 2001-08-28
RU2207850C2 (ru) 2003-07-10
FR2774591B1 (fr) 2000-05-05
EP1054665B1 (de) 2001-08-29
KR100567608B1 (ko) 2006-04-04
AU746821B2 (en) 2002-05-02
PL342665A1 (en) 2001-07-02
HK1034913A1 (en) 2001-11-09
WO1999040904A2 (en) 1999-08-19
TW518222B (en) 2003-01-21
DK1054665T3 (da) 2001-12-27
PT1054665E (pt) 2002-02-28
CZ20002828A3 (cs) 2000-11-15
HU224619B1 (hu) 2005-11-28
SK11562000A3 (sk) 2000-12-11
SK283212B6 (sk) 2003-03-04
AR018286A1 (es) 2001-11-14
DE69900249T2 (de) 2002-06-13
NO20004056L (no) 2000-08-11
CN1151785C (zh) 2004-06-02
HUP0100801A3 (en) 2001-12-28
UA70315C2 (en) 2004-10-15
US6372790B1 (en) 2002-04-16
WO1999040904A3 (en) 1999-09-30
AU2923399A (en) 1999-08-30
JP2002502869A (ja) 2002-01-29

Similar Documents

Publication Publication Date Title
ID26254A (id) Komposisi farmasi yang terdiri dari satu gabungan antara metformin dan fibrate, dan penggunaannya dalam penyiapan obat-obatan yang ditujukan untuk menurukan hiperglikaemia
ID23789A (id) Turunan-turunan amida heteroaril-heksanoat, pembuatannya dan penggunaannya sebagai penghambat selektif dari mip-1, alfa yang diikat ke reseptor ccr1-nya
ID26022A (id) Bentuk galenic pelepasan yang telah diperpanjang dan pelepasan lanjutan yang terdiri dari bahan peningkat absorpsi yang dapat diberikan melalui mulut dan penggunaan bahan peningkat absorpsi tersebut
ID25427A (id) Proses-proses dan zat-zat antara untuk membuat senyawa-senyawa anti-kanker
ID27922A (id) KOMPOSISI FARMASETIKAL DAN PENGGUNAAN DARI ANDROST-5-ENA-3β, 17β-DIOL
GB2335357A (en) Chitosan-gelatin A microparticles
ID26945A (id) Komposisi farmasi yang mengandung misel yang terdiri dari glukokortikosteroid lipofilik dan hanya satu surfaktan
ID23673A (id) Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat
HUP0101419A3 (en) Compounds that inhibit the binding of integrins to their receptors and pharmaceutical compositions containing them
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
ID25784A (id) Bentuk dosis oral padat yang terdiri dari suatu kombinasi metformin dan glibernclamida
ID22873A (id) Senyawa-senyawa heterosiklik dan pemakaiannya untuk menginhibisi b-amyloid peptida
EE9700031A (et) Pürido-liitunud tienüül- ja furanüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
ID27757A (id) Indolinona-indolinona tersubstitusi baru, preparasi dan penggunaannya sebagai obat
FI951966A7 (fi) Uudet polyeeniyhdisteet, niitä sisältävät farmaseuttiset ja kosmeettiset koostumukset ja niiden käyttö
FI861923A7 (fi) Suulakepuristettavien mikropartikkeleidenvalmistuksessa käytettäviä koostumuksia, jotka aiheuttavat biologisestaktiivisen aineen pitkittyneen vapautumisen, ja näin saadut mikropartikkelit.
DE60015893D1 (de) Zusammensetzung enthaltend ein carnitine und glutathion, zur erhöhung der absorption von glutathion und zur synergisierung seiner effekte
HUP0202184A3 (en) Propanoic acid derivatives that inhibit the binding of integrins to their receptors, pharmaceutical compositions containing them and their use
FI970094A7 (fi) Substituoidut bentsamidiinit, niiden valmistus ja käyttö lääkeaineena
ID26955A (id) Komposisi farmasi homogen yang terdiri dari abacavir, lamivudin dan zidovudin
ID26040A (id) Komposisi katalitik yang terdiri dari senyawa titanium, senyawa amina fosfor; pembuatan dan penggunaannya
IS6378A (is) Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau
MX9505181A (es) Utilizacion de un antagonista de la substancia p en una composicion farmaceutica para tratar desordenes de la piel de origen neurogenico.
HUP9902166A3 (en) Substituted benzamide derivatives having anticonvulsant activity, preparation and use thereof, pharmaceutical compositions containing these compounds
ID23141A (id) Bubuk karet yang terdiri dari bahan-bahan pengisi yang dimodifikasi, proses untuk membuatnya dan penggunaannya